Butanoic acid,(3R,5S,5aR,6R,7S,9R,9aS)-6-(acetyloxy)octahydro-2,2,5a,9-tetramethyl-5-[[(2E)-1-oxo-3-phenyl-2-propenyl]oxy]-2H-3,9a-methano-1-benzoxepin-7-ylester (9CI)
| Product Information | |
|---|---|
| Product Number: | AX-DRQA |
| Product Name: | Butanoic acid,(3R,5S,5aR,6R,7S,9R,9aS)-6-(acetyloxy)octahydro-2,2,5a,9-tetramethyl-5-[[(2E)-1-oxo-3-phenyl-2-propenyl]oxy]-2H-3,9a-methano-1-benzoxepin-7-ylester (9CI) |
| CAS: | 145940-84-7 |
| MW: | |
| Synonyms: | Butanoicacid,6-(acetyloxy)octahydro-2,2,5a,9-tetramethyl-5-[(1-oxo-3-phenyl-2-propenyl)oxy]-2H-3,9a-methano-1-benzoxepin-7-ylester, [3R-[3a,5b(E),5aa,6a,7a,9a,9aa]]-; 2H-3,9a-Methano-1-benzoxepin, butanoic acid deriv.; Triptogelin E 7 |
| EINECS: | |
| Density: | |
| Melting Point: | |
| Boiling Point: | |
| Flash Point: | |
| Solubility: | |
| Risk Codes: | |
| Transport Information:: | |